跳至主要内容
临床试验/CTRI/2020/07/026471
CTRI/2020/07/026471尚未招募2 期

A prospective, non-randomized, single-arm interventional study to assess the safety and efficacy of Siddha Sasthric Medicines â?? Fixed Regimen in the prevention of COVID-19 disease progression of asymptomatic, and mild at Siddha COVID Care Centre, Chennai, 2020 (SSM-FiRe) - SSM-FiRe

The Directorate of Indian Medicine and Homoeopathy0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • COVID -19 Positive as determined by RT-PCR or other approved commercial or public health assay
  • Willing to provide written/digital informed consent.
  • COVID - 19 Positive with no clinical signs
  • COVID - 19 Positive with mild symptoms â?? Fever, Cough, Sneezing, Sore Throat, Throat Pain, Malaise, Tiredness

排除标准

  • Pregnant and lactating females
  • COVID - 19 Positive with Severe symptoms â?? Respiratory distress ( >24 breath per minute), Oxygen saturation <90% at rest, Respiratory failure, Need of Mechanical Ventilation, Septic shock, Non-respiratory organ failure
  • Chronic Renal Failure requiring dialysis (eGFR < 30)
  • Known cases of uncontrolled Diabetes ( >10% HbA1c)
  • Subjects having any medical or surgical condition that would require immediate medical or surgical intervention at the time of screening
  • Subjects having immune-compromised status like HIV, Hepatitis, Tuberculosis, Cancer, etc.
  • Participants taking Steroid treatment and or any kind of immunosuppressive therapy
  • Participants participating in any other clinical study or having participated in any other study 1 month prior to screening in the present study.
  • Participants having a past history of allergy to Siddha medicine.
  • Participants with Hb - <7 g/d

研究者

发起方
The Directorate of Indian Medicine and Homoeopathy

相似试验